Cholesterol jab: Why gene silencing drugs may work better than current treatments
The NHS has very recently approved a new cholesterol-lowering jab which will be offered to 300,000 people over the next three years.
Sep 10, 2021
0
3
The NHS has very recently approved a new cholesterol-lowering jab which will be offered to 300,000 people over the next three years.
Sep 10, 2021
0
3
A new study from Linköping University has shown that the tumor-inhibiting gene TET2 is silenced in a large fraction of cases of acute lymphoblastic leukemia (ALL) in children. The scientists show that the gene can be reactivated ...
Aug 25, 2021
0
294
Opioid therapy is complex. In recent years, a rise in opioid-related deaths and changing prescribing guidelines and regulatory policies have led many physicians to reduce daily doses for patients prescribed stable opioid ...
Aug 3, 2021
1
69
Ateam of scientists estimates that providing patients with depression with the tools to quit smoking could save as many as 125,000 lives over the next 80 years. That number jumps to 203,000 when extended to people with depression ...
Aug 3, 2021
0
5
A combination of the kinase-inhibitor drug cabozantinib and the immunotherapy drug nivolumab can make curative surgery possible in some liver cancer patients who would normally not be considered surgery candidates.
Jul 29, 2021
0
249
In the early and thus far most devastating stages of the COVID-19 pandemic, scientists were at a near loss on how to treat the deadly disease. The public was desperate for information. Consequently, two antimalarial drugs—chloroquine ...
Jul 28, 2021
4
3
In a major advancement in the field of gene therapy for rare and devastating diseases, researchers at Children's Hospital of Philadelphia (CHOP) have developed a "dimmer switch" system that can control levels of proteins ...
Jul 28, 2021
0
294
Liver cancer is one of the most common cancer types worldwide and is especially common in China. A collaborative effort between researchers at the Netherlands Cancer Institute and Shanghai using CRISPR/Cas has led to the ...
Jul 21, 2021
0
184
The oral targeted therapy drug ibrutinib is an effective treatment option for high-risk hairy cell leukemia, according to a new study conducted by researchers at The Ohio State University Comprehensive Cancer Center—Arthur ...
Jul 21, 2021
0
1
New research led by investigators at Massachusetts General Hospital (MGH) and Massachusetts Eye and Ear indicates that the blood pressure drug losartan may benefit patients with neurofibromatosis type 2 (NF2), a hereditary ...
Jul 15, 2021
0
13